Legal Opinion
Argentum Pharmaceuticals LLC v. Novartis Pharmaceuticals Corp.
Court of Appeals for the Federal Circuit
Decided April 23, 2020No. 18-2273PublishedCited by 1 opinion
1Opinion of the Court
Case: 18-2273 Document: 13 Page: 1 Filed: 04/23/2020 United States Court of Appeals for the Federal Circuit ______________________ ARGENTUM PHARMACEUTICALS LLC, Appellant v. NOVARTIS PHARMACEUTICALS CORPORATION, Appellee ______________________ 2018-2273 ______________________ Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in Nos. IPR2017- 00854, IPR2017-01550, IPR2017-01929, IPR2017-01946. ______________________ Decided: April 23, 2020 ______________________ TERESA STANEK REA, Crowell & Moring, LLP, Wash- ington, DC, argued for appellant. Also…
2Cases cited9 opinions
- Lujan v. Defenders of WildlifeSupreme Court of the United States · 1992
- Spokeo, Inc. v. RobinsSupreme Court of the United States · 2016
- Consumer Watchdog v. Wisconsin Alumni Research FoundationCourt of Appeals for the Federal Circuit · 2014
- Phigenix, Inc. v. Immunogen, Inc.Court of Appeals for the Federal Circuit · 2017
- Jtekt Corporation v. Gkn Automotive Ltd.Court of Appeals for the Federal Circuit · 2018
4 more not listed; retrieve them via the Exa API.
3Cited by1 opinion
- Apple Inc. v. Qualcomm IncorporatedCourt of Appeals for the Federal Circuit · 2021